Status:
UNKNOWN
Non-Pharmacological Treatments and Cognitive Impairment (NPT-CI2019)
Lead Sponsor:
IRCCS National Neurological Institute "C. Mondino" Foundation
Conditions:
Cognitive Impairment
Eligibility:
All Genders
50-85 years
Phase:
NA
Brief Summary
The prevalence of neurodegenerative diseases is expected to increase over the next years, in parallel with the aging of the world population. Therefore, it is important to identify new methods to prev...
Detailed Description
Non-pharmacological intervention may represent adjunctive therapy to medications in order to delay the onset of the cognitive deficits or dementia. Moreover, increasing evidence suggests that environm...
Eligibility Criteria
Inclusion
- presence of mild dementia or mild cognitive impairment;
- age between 50 and 85 years;
- educational level ≥ 5 years.
Exclusion
- pre-existing cognitive impairment (e.g. aphasia, neglect);
- severe disturbances in consciousness;
- concomitant severe psychiatric disease or others neurological conditions (e.g. depression and behavioural disorders).
Key Trial Info
Start Date :
March 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2020
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT04118686
Start Date
March 15 2017
End Date
December 15 2020
Last Update
October 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Struttura Semplice Neuropsicologia Clinica/ Centro UVA
Pavia, Italy, 27100